HBsAg seropositivity |
England
|
Soldan K et al., 2003 [17] |
0.316 |
- |
1.17
|
Gay NJ et al., 1999 [18]
|
-
|
0.37
|
India
|
Bhattacharya P et al., 2007 [19] |
1.66 |
- |
1.45
|
Batham A et al., 2007 [20]
|
-
|
2.4
|
Greece (Crete)
|
Koulentaki M et al., 1999 [21]
|
0.401
|
0.6
|
1.5
|
|
Durro V et al., 2010 [22] |
6.7 |
- |
1.21
|
Albania
|
Kondili LA et al., 2007 [23]
|
-
|
8.1
|
Croatia
|
Grgicevic D et al., 2000 [11]
|
0.341
|
0.4
|
1.17
|
Turkey
|
Acar A et al., 2010 [24] |
1.76 |
- |
1.70
|
Pirnar A et al., 1976 [25]
|
-
|
3
|
Anti-HCV seropositivity |
England
|
Soldan K et al., 2003 [17]
|
0.16
|
0.2
|
1.25
|
India
|
Bhattacharya P et al., 2007 [19]
|
0.35
|
0.87
|
2.49
|
Greece |
Koulentaki M et al., 1999 [21] |
0.382 |
- |
3.27 |
Goritsas C et al., 2000 [10] |
- |
1.25 |
Croatia |
Grgicevic D et al., 2000 [11] |
0.26 |
1 |
3.85 |